Pre-market stock movers are worth checking on Friday as we lay out all of the biggest stories this morning!
Moving stocks this morning are delisting updates, a private placement, clinical trial results and more.
Let’s get into that news below!
Biggest Pre-Market Stock Movers: 10 Top Gainers
- Ainos (NASDAQ:AIMD) stock is rocketing more than 106% alongside heavy pre-market trading.
- Dermata Therapeutics (NASDAQ:DRMA) shares are soaring over 57% after getting a .
- Immunic (NASDAQ:IMUX) stock is surging close to 35% after announcing a .
- Safe & Green Development (NASDAQ:SGD) shares are gaining more than 32% with strong early morning trading.
- Inspire Veterinary (NASDAQ:IVP) stock is increasing by almost 16% on an updated .
- Canoo (NASDAQ:GOEV) shares are rising over 14% .
- Intelligent Bio Solutions (NASDAQ:INBS) stock is heading more than 10% higher on .
- Fusion Pharmaceuticals (NASDAQ:FUSN) shares are getting more than a 10% boost after providing a .
- Trio Petroleum (NYSEMKT:TPET) stock is jumping more than 10% after .
- Polished.com (NYSEMKT:POL) is up over 9% without any clear news this morning.
10 Top Losers
- CISO Global (NASDAQ:CISO) stock is plummeting more than 34% alongside a .
- Applied Therapeutics (NASDAQ:APLT) stock is diving over 27% alongside .
- Alaunos Therapeutics (NASDAQ:TCRT) shares are tumbling more than 21% on Friday morning.
- Allogene Therapeutics (NASDAQ:ALLO) stock is taking an over 21% beating despite .
- E-Home Household Service (NASDAQ:EJH) shares are sliding more than 21% on Friday.
- Smart for Life (NASDAQ:SMFL) stock is falling over 20% without any apparent news.
- Kore Group (NYSE:KORE) shares are decreasing more than 18% this morning.
- Avenue Therapeutics (NASDAQ:ATXI) stock is slipping over 17% .
- Voyager Therapeutics (NASDAQ:VYGR) shares are dipping more than 15% with .
- Theravance Biopharma (NASDAQ:TBPH) stock closes out our pre-market movers down over 15% on .
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
